Halcyon 4.0 Imaging System for Cancer Radiation Planning
(Dragon Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a new radiotherapy system called Halcyon 4.0 to see if it can quickly and safely capture images needed for planning cancer treatments. The goal is to improve the speed and safety of radiation therapy planning for cancer patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Is the Halcyon 4.0 Imaging System safe for use in humans?
How does the Halcyon 4.0 Imaging System for Cancer Radiation Planning differ from other treatments?
The Halcyon 4.0 system is unique because it offers fast and efficient delivery of radiation therapy with improved sparing of healthy organs, using a single-energy, flattening-filter-free beam and an enclosed bore design. It simplifies the treatment process with automatic imaging and alignment, making it suitable for clinics with limited resources.12456
What data supports the effectiveness of the Halcyon 4.0 system for cancer radiation planning?
Research shows that the Halcyon system provides fast and efficient radiation treatment with good accuracy, especially for breast and cervical cancer. It reduces radiation exposure to nearby organs and shortens treatment time compared to other systems, making it a promising option for cancer radiation therapy.12678
Who Is on the Research Team?
Pamela Samson, M.D., MPHS
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are set to receive radiation therapy for certain cancers (brain, head and neck, lung, stomach, colon) and can consent to the study. Women must not be pregnant. If IV contrast is used in the study, participants need normal or stable kidney function.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Patients undergo imaging on the Halcyon 4.0 system to evaluate image quality for radiation treatment planning
Follow-up
Participants are monitored for safety and effectiveness after imaging
What Are the Treatments Tested in This Trial?
Interventions
- Halcyon 4.0 system
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
Varian Medical Systems
Industry Sponsor
Dow R. Wilson
Varian Medical Systems
Chief Executive Officer since 2012
MBA from Dartmouth's Amos Tuck School of Business, BA from Brigham Young University
Dr. Deepak Khuntia
Varian Medical Systems
Chief Medical Officer since 2020
MD from the University of Cambridge, PhD from the University of Leicester